Medscape Medical NewsAll articles

Critical Care Suite with Endotracheal Tube Positing AI algorithm

GE Medical Systems, LLC • Radiology • 10/29/2021

510(k)IEC 62304 Class B
FDA Summary PDF

Device Purpose

The Critical Care Suite with Endotracheal Tube Positioning AI Algorithm aims to improve endotracheal tube placement verification by automatically analyzing frontal chest X-rays to detect the tube, locate its tip and the carina, and quantify the intervening distance for healthcare professional review. This system employs a locked deep learning AI model to process radiological images and provide these quantitative measurements for adult patients, deployable on various clinical computing platforms.

Summary

The Critical Care Suite with Endotracheal Tube Positioning AI Algorithm is a software tool designed for the automated analysis of frontal chest X-rays in adult-sized patients. Its primary purpose is to assist healthcare professionals, including those placing or assessing endotracheal tubes (ETTs) and radiologists, by accurately identifying and localizing the ETT, its tip, and the carina; the system then automatically calculates the vertical distance between the ETT tip and the carina, presenting this information as an on-screen image overlay and transmitting it to radiologists for review. This quantification tool, an addition to the existing Critical Care Suite, aims to aid in determining the proper placement of ETTs but is not intended to replace full patient evaluation or serve as the sole basis for diagnosis. The underlying technology of the Endotracheal Tube Positioning AI Algorithm is a deep learning, locked AI system capable of deployment across various computational platforms, including PACS, on-premise servers, cloud environments, and directly on digital X-ray imaging systems. While it analyzes chest X-rays, its core AI methodology for anatomical identification and quantification is similar to technologies used for different imaging modalities. Clinical performance testing against a ground truth dataset demonstrated high accuracy, with an Area Under the Curve (AUC) of 0.9999 for ETT detection, a 99.41% sensitivity, and 100% specificity, alongside an ETT tip to carina distance measurement success rate of 98.51% and comparable success rates for carina and ETT tip localization.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

Endotracheal TubeArtificial IntelligenceChest X-rayImage AnalysisCarina LocalizationETT PositioningDeep LearningAutomated QuantificationMedical Image ProcessingCritical Care Suite

Device Metadata

Submission Number
K211161
Company
GE Medical Systems, LLC
Panel
Radiology
Product Code
N/A
Data Type
Images
Clinical Function
Intervention
AI Function
Analysis
AI Subclass
quantification/feature localization

Relevant Clinical Questions

  • Q1. How does the Endotracheal Tube Positioning AI algorithm's performance vary with different patient anatomies (e.g., obesity, scoliosis, pre-existing lung conditions) or common image quality variations encountered in portable chest X-rays?; What specific image features does the deep learning model primarily utilize to identify the carina and endotracheal tube tip, and how robust is its detection in the presence of anatomical mimics or overlying structures?; Given that the algorithm calculates distance in the 2D imaging plane, what is the quantified range of potential discrepancy when compared to the true 3D anatomical distance, and are there guidelines for interpreting this 2D measurement in clinically borderline cases?; How does the integration of this AI tool into various deployment platforms (e.g., on-device on the X-ray system, PACS, cloud) impact processing time, real-time feedback availability to the intubating clinician, and overall workflow efficiency, particularly in emergency settings?; What was the demographic and clinical diversity (including ETT types, patient conditions, prevalence of malpositioned tubes) of the ground truth dataset used for clinical testing, and how were ambiguous or difficult cases adjudicated for establishing this ground truth?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score20/100
SBOM Evidence⚠ Not mentioned in summary
Cyber Risk Assessment⚠ Not mentioned in summary
Postmarket Plan⚠ Not mentioned in summary
§524B ApplicableNo

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(deep learning, algorithm, dataset, ground truth)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials(cloud, server, platform)
✓ Detected
HBOMHardware Bill of Materials(on-device)
✓ Detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials(deployment, environment)
✓ Detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, SaaSBOM, HBOM, OBOM detected in AI-generated device summary.

• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, CBOM, VDR/VEX. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
Critical Care Suite with Endotracheal Tube Positing AI algorithm - GE Medical Systems, LLC | ESL FDA AI Device Intelligence